PT92800A - Processo para a preparacao de 1-heteroaril-3-acil-2-oxindoles uteis como anti-inflamatorios - Google Patents

Processo para a preparacao de 1-heteroaril-3-acil-2-oxindoles uteis como anti-inflamatorios

Info

Publication number
PT92800A
PT92800A PT92800A PT9280090A PT92800A PT 92800 A PT92800 A PT 92800A PT 92800 A PT92800 A PT 92800A PT 9280090 A PT9280090 A PT 9280090A PT 92800 A PT92800 A PT 92800A
Authority
PT
Portugal
Prior art keywords
oxindoles
acyl
heteroaril
uti
inflammatory
Prior art date
Application number
PT92800A
Other languages
English (en)
Other versions
PT92800B (pt
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT92800A publication Critical patent/PT92800A/pt
Publication of PT92800B publication Critical patent/PT92800B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
PT92800A 1989-01-10 1990-01-08 Processo para a preparacao de 1-heteroaril-3-acil-2-oxindoles uteis como anti-inflamatorios PT92800B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/000079 WO1990008145A1 (en) 1989-01-10 1989-01-10 Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles

Publications (2)

Publication Number Publication Date
PT92800A true PT92800A (pt) 1990-07-31
PT92800B PT92800B (pt) 1995-12-29

Family

ID=22214772

Family Applications (1)

Application Number Title Priority Date Filing Date
PT92800A PT92800B (pt) 1989-01-10 1990-01-08 Processo para a preparacao de 1-heteroaril-3-acil-2-oxindoles uteis como anti-inflamatorios

Country Status (18)

Country Link
EP (1) EP0378358B1 (pt)
JP (1) JPH0692400B2 (pt)
KR (1) KR920006785B1 (pt)
AT (1) ATE96793T1 (pt)
AU (1) AU616336B2 (pt)
CA (1) CA2007655C (pt)
DE (1) DE69004272T2 (pt)
DK (1) DK0378358T3 (pt)
ES (1) ES2060007T3 (pt)
FI (1) FI92827C (pt)
HU (1) HU215112B (pt)
IE (1) IE62143B1 (pt)
IL (1) IL92962A (pt)
NO (1) NO179103C (pt)
NZ (1) NZ232039A (pt)
PT (1) PT92800B (pt)
WO (1) WO1990008145A1 (pt)
ZA (1) ZA90139B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2886541A1 (en) * 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases
CN108456205B (zh) * 2018-05-21 2021-06-04 深圳市众康动保科技有限公司 一种3,3二取代羟基吲哚化合物的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053613A (en) * 1975-09-17 1977-10-11 E. R. Squibb & Sons, Inc. 1,3,thiazolinyl and 1,3 thiazinyl substituted indolinones
EP0276500B1 (en) * 1984-02-07 1991-05-15 Pfizer Inc. 2-oxindole intermediates
US4721712A (en) * 1984-06-12 1988-01-26 Pfizer Inc. 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
IN163263B (pt) * 1984-02-07 1988-08-27 Pfizer
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
HU203238B (en) * 1984-08-24 1991-06-28 Pfizer Process for producing antiinflammatory tricyclic oxindole derivatives
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4686224A (en) * 1984-10-31 1987-08-11 Pfizer Inc. Oxindole antiinflammatory agents
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds

Also Published As

Publication number Publication date
NO912694L (no) 1991-07-09
HUT62292A (en) 1993-04-28
NO912694D0 (no) 1991-07-09
CA2007655C (en) 1996-10-22
NO179103B (no) 1996-04-29
EP0378358B1 (en) 1993-11-03
AU4781690A (en) 1990-07-19
ZA90139B (en) 1991-08-28
EP0378358A1 (en) 1990-07-18
ES2060007T3 (es) 1994-11-16
ATE96793T1 (de) 1993-11-15
NO179103C (no) 1996-08-07
KR900011762A (ko) 1990-08-02
DK0378358T3 (da) 1993-12-06
JPH02270868A (ja) 1990-11-05
JPH0692400B2 (ja) 1994-11-16
FI92827B (fi) 1994-09-30
HU215112B (hu) 1998-12-28
CA2007655A1 (en) 1991-07-12
AU616336B2 (en) 1991-10-24
DE69004272D1 (de) 1993-12-09
IE900075L (en) 1990-07-10
PT92800B (pt) 1995-12-29
FI92827C (fi) 1995-01-10
IL92962A (en) 1995-01-24
WO1990008145A1 (en) 1990-07-26
IE62143B1 (en) 1994-12-14
KR920006785B1 (ko) 1992-08-17
DE69004272T2 (de) 1994-02-24
FI913324A0 (fi) 1991-07-09
NZ232039A (en) 1991-07-26

Similar Documents

Publication Publication Date Title
CR6368A (es) Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos
FI970246A7 (fi) Dihydrobentsofuraanit
PT1021449E (pt) Derivados de esteres hidroxiaceticos processo para a sua preparacao e sua utilizacao como intermediarios de sintese
FI874395A0 (fi) Hydraulisk cylinderanordning foer avkaenning och reglering av avstaondet mellan pressbord.
PT863887E (pt) Intermediarios para a hemisintese de taxanos e seus processos de preparacao
BR0008309A (pt) Processo de criar uma superfìcie de concreto com padrão com o auxìlio de um agente retardador de superfìcie de concreto
ECSP034917A (es) Nuevos derivados de acido sulfonico
GT200000049A (es) Compuestos quimicos.
PT92800A (pt) Processo para a preparacao de 1-heteroaril-3-acil-2-oxindoles uteis como anti-inflamatorios
BR9909841A (pt) Derivados de pirazolinona, agente de controle de doença das plantas, compostos de pirazolinona, processo para controlar doenças das plantas, e, uso dos derivados de pirazolinona
AR020950A1 (es) Compuestos de 3-(fenil sustituido)-5-tienil-1,2,4-triazolo con actividad contra la mosca blanca
ATE230745T1 (de) Polycyclische azaindolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ES2156917T3 (es) Proceso para la preparacion de derivados de 1-(4,5-dihidro-2-tiazolil)-3-azetidina-tiol.
IE801068L (en) Substituted acetophenones.
ES509636A0 (es) "procedimiento para preparar nuevos compuestos de aroilimidazol-2-onas".
MY104238A (en) Prodrugs of antiinflammatory 3-acyl-2-oxindole-1 -carboxamides.
EP0285561A3 (de) Parasitizide und insektizide Milbemycin-Derivate
WO2001012642A3 (de) Nucleosidderivate und verfahren zu deren herstellung
FI913325A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1-heteroaryylioksoindoli-3-karboksamidien valmistamiseksi
ES2080898T3 (es) Procedimiento para la preparacion de una ciclobutanona opticamente activa, un producto intermedio en la sintesis de un nucleosido de ciclobutano opticamente activo.
ITMI910607A0 (it) Procedimento per il trattamento di rigenerazione a cariche di terra usata da fonderia prevalentemente legata ad argilla
UY26435A1 (es) Compuestos bis-básicos como inhibidores de triptasa, procedimiento para su preparación y su utilización como medicamentos.
ATE239017T1 (de) 1,4-dihydropyridin-5-carbonsäureester-derivate und verfahren zu ihrer herstellung
NO934399L (no) Tioesterderivater av 3'-O-propargyl-trifluortymidin, fremgangsmåte for fremstilling samt anvendelse av slike
ES2054938T3 (es) Una composicion y metodo herbicidas.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19950913

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20050314